{"id":"standard-course-macrolide","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL411735","moleculeType":"Small molecule","molecularWeight":"1021.34"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This action prevents the formation of peptide bonds between amino acids, ultimately leading to the death of the bacterial cell. Macrolides have a broad spectrum of activity and are effective against a wide range of Gram-positive and Gram-negative bacteria.","oneSentence":"Macrolides inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:09.587Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute exacerbations of chronic bronchitis"},{"name":"Mild to moderate asthma"}]},"trialDetails":[{"nctId":"NCT04469530","phase":"PHASE2","title":"Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors","status":"RECRUITING","sponsor":"Emory University","startDate":"2020-09-16","conditions":"Solid Tumor","enrollment":55},{"nctId":"NCT07320612","phase":"PHASE1","title":"Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome","status":"COMPLETED","sponsor":"University of Child Health Sciences and Children's Hospital, Lahore","startDate":"2025-03-08","conditions":"Nephrotic Syndrome","enrollment":160},{"nctId":"NCT02754583","phase":"PHASE3","title":"Sanitation, Water, and Instruction in Face-washing for Trachoma I/II","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-12-05","conditions":"Trachoma","enrollment":47605},{"nctId":"NCT00877500","phase":"PHASE2","title":"Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-03-30","conditions":"Bilateral Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma","enrollment":116},{"nctId":"NCT06010719","phase":"PHASE4","title":"Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-10-23","conditions":"Malnutrition, Child, Severe Acute Malnutrition","enrollment":3000},{"nctId":"NCT01737502","phase":"PHASE1, PHASE2","title":"Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-05-14","conditions":"Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma","enrollment":29},{"nctId":"NCT07120490","phase":"NA","title":"STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-10","conditions":"Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Fecal Microbiota Transplantation (FMT)","enrollment":424},{"nctId":"NCT07107477","phase":"PHASE3","title":"TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden","status":"RECRUITING","sponsor":"The Central and Eastern European Gynecologic Oncology Group","startDate":"2025-05-01","conditions":"Preterm Premature Rupture of Membranes (PPROM)","enrollment":138},{"nctId":"NCT05345457","phase":"PHASE4","title":"Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2023-01-13","conditions":"Pregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy)","enrollment":88},{"nctId":"NCT05473234","phase":"PHASE3","title":"Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-10-06","conditions":"Severe Acute Malnutrition","enrollment":310},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT02389036","phase":"PHASE3","title":"Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients","status":"COMPLETED","sponsor":"The George Institute","startDate":"2017-05-01","conditions":"Critical Illness, Sepsis, Septic Shock","enrollment":20010},{"nctId":"NCT03328104","phase":"PHASE1","title":"Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-07-24","conditions":"Lymphoblastic Leukemia, Lymphoblastic Lymphoma","enrollment":8},{"nctId":"NCT05342532","phase":"PHASE4","title":"High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-06-12","conditions":"Helicobacter Pylori Infection","enrollment":112},{"nctId":"NCT03568643","phase":"PHASE3","title":"Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-06-03","conditions":"Uncomplicated Severe Acute Malnutrition","enrollment":301},{"nctId":"NCT03576313","phase":"PHASE3","title":"Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2018-08-11","conditions":"Malaria","enrollment":4939},{"nctId":"NCT04844905","phase":"PHASE3","title":"Adjunctive Ivermectin Mass Drug Administration for Malaria Control","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-05-03","conditions":"Malaria,Falciparum, Neglected Tropical Diseases, Strongyloidiasis","enrollment":24000},{"nctId":"NCT03894007","phase":"PHASE2","title":"Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer","status":"TERMINATED","sponsor":"Renske Altena","startDate":"2019-05-23","conditions":"Early-stage Breast Cancer, HER2-positive Breast Cancer","enrollment":6},{"nctId":"NCT04937569","phase":"PHASE3","title":"Ivermectin Versus Standard Treatment in Mild COVID-19","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-07-01","conditions":"Covid19","enrollment":1644},{"nctId":"NCT04668469","phase":"NA","title":"Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic","status":"COMPLETED","sponsor":"Benha University","startDate":"2020-06-08","conditions":"Covid19","enrollment":600},{"nctId":"NCT02568839","phase":"PHASE2, PHASE3","title":"Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thomas Hatschek","startDate":"2014-11","conditions":"Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer","enrollment":202},{"nctId":"NCT00504348","phase":"PHASE2, PHASE3","title":"Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus","status":"COMPLETED","sponsor":"Tokyo Medical and Dental University","startDate":"2007-07","conditions":"Interstitial Pneumonitis, Polymyositis, Dermatomyositis","enrollment":25},{"nctId":"NCT02511353","phase":"PHASE2","title":"Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2015-07","conditions":"Malaria","enrollment":141},{"nctId":"NCT01005316","phase":"","title":"Alloantibodies in Pediatric Heart Transplantation","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-01","conditions":"Pediatric Heart Transplantation, Pediatric Heart Transplant Recipients","enrollment":290},{"nctId":"NCT01825408","phase":"PHASE4","title":"Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2013-02","conditions":"Sinusitis","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":48,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Standard course macrolide","genericName":"Standard course macrolide","companyName":"UMC Utrecht","companyId":"umc-utrecht","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Macrolides inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit. Used for Community-acquired pneumonia, Acute exacerbations of chronic bronchitis, Mild to moderate asthma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}